Dynamics of a Breast Cancer Model for Neutropenia Case due to Chemotherapy Effects

M. Ivan Ariful Fathoni, Fajar Adi-Kusumo, Gunardi Gunardi and Susanna Hilda Hutajulu

International Journal of Differential Equations, 2021, vol. 2021, 1-8

Abstract:

Breast cancer is a type of carcinoma with a high prevalence. The treatment of breast cancer through chemotherapy can cause a risk to healthy cells throughout the body. The neutrophil is one of the cells that is influenced by chemotherapy drugs. Chemotherapy-induced neutropenia is one of the most common toxic effects experienced by patients and often threatens chemotherapy to use efficiency. In this paper, we introduce an interaction model between blood components, i.e., neutrophil, lymphocytes, and albumin, with chemotherapy drugs. The model is important to understand the neutropenia effect due to chemotherapy in mathematical perspective and to calculate breast cancer patients’ survival level. Our model is a four-dimensional system of the first-order ODE with 13-dimensional parameter space. We focus our study for understanding the steady-state conditions and the bifurcations when the parameter values are varied. Here, we also study the role of albumin for reducing the neutropenia effects for breast cancer patients mathematically, where the results can be used as an alternative solution for treating neutropenia in a breast cancer case.

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
http://downloads.hindawi.com/journals/IJDE/2021/3401639.pdf (application/pdf)
http://downloads.hindawi.com/journals/IJDE/2021/3401639.xml (text/xml)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hin:jnijde:3401639

DOI: 10.1155/2021/3401639

Access Statistics for this article

More articles in International Journal of Differential Equations from Hindawi
Bibliographic data for series maintained by Mohamed Abdelhakeem ().